# Bolt Biotherapeutics, Inc.: Form SCHEDULE 13D/A, filed Feb 17, 2026

- Company: [Bolt Biotherapeutics, Inc.](/companies/bolt.md) (CIK 1641281)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-17
- Accepted by EDGAR: Feb 17, 2026, 20:11 ET
- Period: not reported
- Accession: 0001012975-26-000173
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1641281/000101297526000173/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1641281/000101297526000173/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1641281/000101297526000173/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001012975-26-000173. Last ingested by Listed: Nov 13, 2026, 15:45 ET. No prices; not investment advice.
